
View larger version (57K):
[in a new window]
|
Fig. 4. Pharmacological characterization of the anchoring structure. (A-D) Typical trajectories (red) on fibroblast lamellipodium of latex beads coupled to mGluR5-myc superimposed on a DIC picture of the cell, in the presence of drugs that affect the cytoskeleton. (A) Trajectory in the presence of 1 µM cytochalasin, which depolymerizes actin. (B,C) Trajectories in the presence of 10 µM demecolcine or 1 µM nocodazol, which depolymerize microtubules. (D) Trajectory in the presence of 10 µM taxol, which stabilizes microtubules. Anchorage points are depicted by yellow crosses (A,D). Note that anchorage remains when actin is depolymerized (A) or when microtubule polymerization is favored (D), and is abolished when microtubules are depolymerized (B,C). (E-H) Corresponding diffusion versus time plots. Note the sudden drop in diffusion values in E and the low values recorded from the beginning in H (arrows), corresponding to the yellow crosses in A and D, respectively. (I-J) plots of the mean MSD versus time for control trajectories recorded on fibroblasts in control conditions and in the presence of drugs that affect actin (I) or microtubules (J). Note that the positive curvature of the mean MSD in the presence of taxol (tax) is even higher than in control (ctl), whereas the mean MSD is lower and linear with time in the presence of cytochalasin (cyt) and nocodazol (noc) (P<0.01 and P<0.05, respectively). Insets: blowup of the MSD versus time plots around the origin; J shows the increase in diffusion under nocodazol.
|